Kim, Jiwon
Kang, Seung Hyun
Choi, Yonghyun
Lee, Wonjae
Kim, Nayeong
Tanaka, Masayoshi
Kang, Shink Hyuk
Choi, Jonghoon
Funding for this research was provided by:
National Research Foundation of Korea (2020R1A5A1018052, 2017M3A7B8061942, 2019R1A2C1006018, 2021M3H4A4079629)
Article History
Received: 3 September 2022
Accepted: 13 July 2023
First Online: 24 July 2023
Competing interests
: Dr. Jonghoon Choi is CEO/Founder and Dr. Yonghyun Choi is CTO of the Feynman Institute of Technology at the Nanomedicine Corporation.